 Kathleen Dorris
Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 8 | 2022 | 1000 | 1.720 |
Why?
| | Glioma | 4 | 2021 | 300 | 1.430 |
Why?
| | Spinal Neoplasms | 1 | 2017 | 29 | 0.650 |
Why?
| | Antineoplastic Agents | 3 | 2018 | 2062 | 0.640 |
Why?
| | Ganglioglioma | 1 | 2017 | 34 | 0.640 |
Why?
| | Ependymoma | 4 | 2019 | 155 | 0.630 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 2016 | 55 | 0.620 |
Why?
| | Electric Stimulation Therapy | 1 | 2017 | 71 | 0.600 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 382 | 0.490 |
Why?
| | Histones | 1 | 2017 | 548 | 0.450 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1430 | 0.440 |
Why?
| | Infratentorial Neoplasms | 2 | 2019 | 36 | 0.350 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 65 | 0.350 |
Why?
| | Neoplasm Grading | 2 | 2021 | 262 | 0.240 |
Why?
| | Neoplasms | 1 | 2016 | 2163 | 0.230 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 10 | 0.230 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 18 | 0.230 |
Why?
| | Prognosis | 4 | 2019 | 3592 | 0.220 |
Why?
| | Child | 10 | 2022 | 18757 | 0.220 |
Why?
| | Radiation | 1 | 2021 | 27 | 0.220 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 193 | 0.220 |
Why?
| | Vinblastine | 1 | 2020 | 85 | 0.200 |
Why?
| | Carboplatin | 1 | 2020 | 143 | 0.190 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 20 | 0.190 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 10 | 0.190 |
Why?
| | Optic Chiasm | 1 | 2019 | 17 | 0.190 |
Why?
| | Survival Rate | 2 | 2020 | 1874 | 0.180 |
Why?
| | Craniopharyngioma | 1 | 2019 | 71 | 0.170 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 207 | 0.170 |
Why?
| | Pituitary Neoplasms | 1 | 2019 | 161 | 0.170 |
Why?
| | Combined Modality Therapy | 2 | 2019 | 1230 | 0.160 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 205 | 0.160 |
Why?
| | Chromosome Aberrations | 1 | 2017 | 149 | 0.160 |
Why?
| | Neuroimaging | 1 | 2019 | 237 | 0.150 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1216 | 0.150 |
Why?
| | Radiotherapy | 1 | 2017 | 197 | 0.150 |
Why?
| | Safety | 1 | 2016 | 330 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2018 | 1590 | 0.130 |
Why?
| | Adolescent | 4 | 2022 | 19192 | 0.130 |
Why?
| | Follow-Up Studies | 2 | 2020 | 5000 | 0.120 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 2933 | 0.120 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1080 | 0.120 |
Why?
| | Humans | 11 | 2022 | 119016 | 0.110 |
Why?
| | Retrospective Studies | 3 | 2022 | 12249 | 0.100 |
Why?
| | Infant | 2 | 2020 | 8377 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3894 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2020 | 5203 | 0.090 |
Why?
| | Child, Preschool | 2 | 2020 | 9875 | 0.090 |
Why?
| | Male | 5 | 2022 | 61786 | 0.080 |
Why?
| | Mutation | 1 | 2017 | 3468 | 0.070 |
Why?
| | Female | 4 | 2022 | 64422 | 0.070 |
Why?
| | Young Adult | 2 | 2021 | 11181 | 0.070 |
Why?
| | Computer Simulation | 2 | 2021 | 948 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2017 | 9492 | 0.060 |
Why?
| | Gene Ontology | 1 | 2021 | 43 | 0.060 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 149 | 0.050 |
Why?
| | Mice, SCID | 1 | 2019 | 372 | 0.050 |
Why?
| | Weight Gain | 1 | 2022 | 507 | 0.040 |
Why?
| | Drug Approval | 1 | 2018 | 80 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 597 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2017 | 26 | 0.040 |
Why?
| | Mucin-1 | 1 | 2017 | 19 | 0.040 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 30 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 1008 | 0.040 |
Why?
| | DNA Methylation | 1 | 2021 | 437 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 499 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 89 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2017 | 131 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 110 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 786 | 0.040 |
Why?
| | Risk Factors | 2 | 2022 | 9266 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 318 | 0.040 |
Why?
| | Transcriptome | 1 | 2021 | 730 | 0.040 |
Why?
| | Algorithms | 1 | 2022 | 1552 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2099 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 560 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2017 | 640 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 2382 | 0.030 |
Why?
| | Cohort Studies | 1 | 2021 | 5129 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2017 | 1432 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2639 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2431 | 0.020 |
Why?
| | Transcription Factors | 1 | 2017 | 1661 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2737 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3266 | 0.020 |
Why?
| | Mice | 1 | 2019 | 15850 | 0.010 |
Why?
| | Animals | 1 | 2019 | 35392 | 0.010 |
Why?
|
|
Dorris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|